Lunit Inc.

KOSDAQ:A328130 Stock Report

Market Cap: ₩1.3t

Lunit Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Beomseok Brandon Suh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenureno data

Recent management updates

Recent updates

Some Confidence Is Lacking In Lunit Inc.'s (KOSDAQ:328130) P/S

Oct 31
Some Confidence Is Lacking In Lunit Inc.'s (KOSDAQ:328130) P/S

Is Lunit (KOSDAQ:328130) Using Too Much Debt?

Aug 18
Is Lunit (KOSDAQ:328130) Using Too Much Debt?

At ₩45,350, Is It Time To Put Lunit Inc. (KOSDAQ:328130) On Your Watch List?

Jun 14
At ₩45,350, Is It Time To Put Lunit Inc. (KOSDAQ:328130) On Your Watch List?

Lunit Inc. (KOSDAQ:328130) Shares Could Be 29% Above Their Intrinsic Value Estimate

May 16
Lunit Inc. (KOSDAQ:328130) Shares Could Be 29% Above Their Intrinsic Value Estimate

Is Lunit (KOSDAQ:328130) A Risky Investment?

Mar 31
Is Lunit (KOSDAQ:328130) A Risky Investment?

Lunit Inc.'s (KOSDAQ:328130) 28% Cheaper Price Remains In Tune With Revenues

Mar 07
Lunit Inc.'s (KOSDAQ:328130) 28% Cheaper Price Remains In Tune With Revenues

Is There Now An Opportunity In Lunit Inc. (KOSDAQ:328130)?

Mar 06
Is There Now An Opportunity In Lunit Inc. (KOSDAQ:328130)?

Subdued Growth No Barrier To Lunit Inc. (KOSDAQ:328130) With Shares Advancing 60%

Nov 20
Subdued Growth No Barrier To Lunit Inc. (KOSDAQ:328130) With Shares Advancing 60%

Here's Why We're Not At All Concerned With Lunit's (KOSDAQ:328130) Cash Burn Situation

Apr 19
Here's Why We're Not At All Concerned With Lunit's (KOSDAQ:328130) Cash Burn Situation

CEO

Beomseok Brandon Suh

no data
Tenure

Mr. Beomseok Brandon Suh is Chief Executive Officer of Lunit Inc. He studied medicine in Seoul National University College of Medicine and is a board certified physician in Family Medicine, trained at Seou...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony S. Paek
Co-Founder & Executive Chairmanno datano datano data
Beomseok Brandon Suh
Chief Executive Officerno datano datano data
Jungin Lee
Co-Founder & Dept Head of Infrastructureno datano data2.62%
₩ 33.4b
Donggeun Yoo
Co-founderno datano data2.19%
₩ 27.9b
Sunggyun Park
Co-Founder & Chief Product Officer of Cancer Screening Groupno datano data1.86%
₩ 23.7b
Kyunghyun Paeng
Co-Founder & Chief Product Officer of Cancer Screening Groupno datano data2.22%
₩ 28.3b
Hyeonseong Park
Chief Financial Officerno datano data0.33%
₩ 4.2b
Jinsub Bae
Dept. Head of Finance & Accounting1.8yrsno datano data
Hyungah Kim
Deparment Head of People2.6yrsno datano data
Ken Nesmith
Chief Business Officer of Business Development Division - Oncology Groupno datano data0.051%
₩ 653.2m
Kihwan Kim
Group Head of Cancer Screening Groupno datano data0.44%
₩ 5.7b
Chang Ahn
Dept. Head of Medicine & Oncology Group1.8yrsno datano data
1.8yrs
Average Tenure

Experienced Management: A328130's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/11 08:56
End of Day Share Price 2025/11/11 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lunit Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jun ChoiMacquarie Research
Hyun-soo HaYuanta Securities Korea Co., Ltd.